Posts With Tag Novo Nordisk

Showing 1 - 2 of 2 Posts

Last updated: 21 days ago

Novo Nordisk's Comeback: The Battle for Weight-Loss Market Dominance

Explore Novo Nordisk's rebound in the weight-loss sector amid competition from Eli Lilly, Pfizer, and others. Key insights for investors in the evolving landscape of obesity treatments.

Novo Nordisk Weight Loss GLP-1 Drugs Eli Lilly Market Trends

Ascendis Pharma 6-K Report: Novo Nordisk Collaboration & $100M Milestone Insight

$ASND

•

Form 6-K

•

2024-12-17

Last updated: 10 months ago

Ascendis Pharma 6-K Report: Novo Nordisk Collaboration & $100M Milestone Insight

Discover Ascendis Pharma's latest 6-K report detailing a strategic collaboration with Novo Nordisk for metabolic disease solutions, including a $100M milestone payment opportunity.

Ascendis Pharma Novo Nordisk TransCon technology metabolic diseases cardiovascular diseases